About Selas-View
SELAS-VIEW Project
Bridging across disciplines and sectors to face intractable and economically unviable diseases.
EPOS-IASIS, Istognosis, KIOS CoE/UCY, the German Oncology Center, and Nicosia General Hospital are thrilled to share the groundbreaking collaboration, bringing you Selas View: an Integrated, Patient-Enabled Solution for Personalized Tumor Monitoring and Prevention of Metastasis.
Cancer metastasis presents a major global challenge. In 2018 alone, 17 million people were diagnosed with cancer, and 9.6 million succumbed to it, with 90% of these deaths attributed to metastasis. The importance of early detection and personalized cancer diagnostics has never been more crucial.
What is Selas View?
Selas View is an innovative, patient-centric platform designed for the minimally-invasive, long-term, continuous monitoring of metastasis in Lung Cancer (LC) – the leading cause of cancer deaths globally. Our pre-clinically validated platform focuses on lung cancer metastasis to the brain, one of the most challenging and costly scenarios.
Key Features
Personalized Implantable Biosensor
Detects circulating biomarkers of metastasis, converting them into optical signals.
Patient Wrist-Band Monitor
A watch-like device that detects emitted light from the biosensor and alerts the patient.
Future IoBT Platform Integration
Envisioned to evolve into an Internet of Bio-Things (IoBT) Platform for a novel precision medicine solution, leveraging cloud data management, mHealth services, and advanced prediction algorithms.
Biosensor Delivery Capsule
A collagen scaffold within a medical-grade syringe for subcutaneous delivery.
Customized Mobile Application
Communicates with the monitor, processes emissions, and informs both the patient and physician.
.
Transforming Metastasis and Liquid Biopsy (LB) Markets
An innovation with strong market creation potential.
Selas View aims to revolutionize the global and sustainable transformation of metastasis monitoring and LB markets. By addressing the emerging Brain Metastasis niche, we’re paving the way towards the burgeoning industry of IoBT, offering vast commercial opportunities.
Join us in this journey towards innovative cancer care and prevention. Together, we can make a significant impact in the fight against cancer.
